CA
1
-9
AEE
74
5
COST
50
2
WMT
68
4
ALL
56
3
L
55
9
SWKS
58
6
CNP
52
3
EBAY
56
2
CAT
53
3
BF.B
57
3
UA
48
-8
MU
67
-3
DRI
63
2
KLAC
74
-2
ABBV
55
4
WU
38
6
LYB
22
2
CPB
44
4
CI
40
4
CA
1
-9
AEE
74
5
COST
50
2
WMT
68
4
ALL
56
3
L
55
9
SWKS
58
6
CNP
52
3
EBAY
56
2
CAT
53
3
BF.B
57
3
UA
48
-8
MU
67
-3
DRI
63
2
KLAC
74
-2
ABBV
55
4
WU
38
6
LYB
22
2
CPB
44
4
CI
40
4
Financhill
Back

Karyopharm Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

KPTI
Karyopharm Therapeutics

Last Price:
$5.41
Seasonality Move:
-5.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Karyopharm Therapeutics Stock Forecast

  • Over the next 52 weeks, Karyopharm Therapeutics has on average historically risen by 1.9% based on the past 11 years of stock performance.
  • Karyopharm Therapeutics has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
  • Is Karyopharm Therapeutics Stock Undervalued?
    The current Karyopharm Therapeutics [KPTI] share price is $5.32. The Score for KPTI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • KPTI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Karyopharm Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Karyopharm Therapeutics has on average historically risen by 1.9% based on the past 11 years of stock performance.

Karyopharm Therapeutics Stock Rating

Sell
40
Karyopharm Therapeutics (KPTI) is a Sell

Is Karyopharm Therapeutics overpriced?

  • Karyopharm Therapeutics has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%

Karyopharm Therapeutics Stock Price History

Is KPTI stock going to rise?

  • The current trend is relatively stagnant and KPTI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com

52-Week Data

52-Week High:
17.85
52-Week Low:
3.51

Prediction Charts

Market Cap:
46M
Price in USD:
5.32
Volume:
36.5K
Beta:
0.90

Technical Analysis

SMA50:
5.55
SMA100:
7.55
SMA200:
9.84
52-Wk Change:
-68.75%

Stock Predictions

  • Is Karyopharm Therapeutics stock public?
    Yes, Karyopharm Therapeutics is a publicly traded company.
  • What is the Karyopharm Therapeutics stock quote today?
    The Karyopharm Therapeutics stock price is 5.32 USD today.
  • How to buy Karyopharm Therapeutics stock online?
    You can buy Karyopharm Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 6.08 6.35 6.41 5.94
Apr-30 6.32 6.75 6.79 6.25
May-1 6.75 6.76 6.99 6.40
May-2 6.73 7.36 7.90 6.73
May-5 7.20 7.09 7.83 7.04
May-6 7.12 6.27 7.42 6.04
May-7 6.30 6.11 6.43 6.01
May-8 6.01 6.15 6.31 5.90
May-9 6.15 6.01 6.71 5.81
May-12 6.16 6.15 6.22 5.60
May-13 5.75 4.92 5.96 4.75
May-14 4.85 4.85 5.22 4.64
May-15 4.88 5.44 5.48 4.85
May-16 5.50 5.32 5.64 5.25

Karyopharm Therapeutics Earnings

Karyopharm Therapeutics Earnings Report: Per Share Karyopharm Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Karyopharm Therapeutics Forecast Revenue Growth

Karyopharm Therapeutics Stock Analysis: Historical quarterly revenues per share for Karyopharm Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $2.02 per share, an increase this year of $0.39 per share, and an increase next year of $5.80 per share.

* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.